Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 20,250 | $34.5 | $698,625 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-10 Option Award | 2025-04-11 4:55 pm | N/A 2035-04-09 | Kalaris Therapeutics Inc. | KLRS | Oxtoby Andrew See Remarks | 287,000 | $0 | 287,000 (Direct) | View |
| 2025-03-18 Option Award | 2025-03-18 5:41 pm | N/A 2034-05-27 | Kalaris Therapeutics Inc. | KLRS | Oxtoby Andrew See Remarks | 476,611 | $0 | 476,611 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:00 pm | N/A 2033-02-27 | CHINOOK THERAPEUTICS INC. | KDNY | Oxtoby Andrew Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 6,345 | $34.5 | 0 (Direct) | View |
| 2020-09-15 Tax Withholding | 2020-09-16 5:19 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 840 | $34.25 | 26,595 (Direct) | View |